Pharmacology · Antidiabetic Drugs (Oral Hypoglycemics, Insulins)

A 45-year-old man with type 2 diabetes and a BMI of 34 kg/m2 is started on acarbose. The mechanism of acarbose involves competitive inhibition of which enzyme?

  • A Dipeptidyl peptidase-4 (DPP-4)
  • B Sodium-glucose cotransporter 2 (SGLT2) in the proximal tubule
  • C Alpha-glucosidase in the small intestinal brush border
  • D Aldose reductase in the polyol pathway
Correct answer: C. Alpha-glucosidase in the small intestinal brush border

Explanation

Acarbose is an alpha-glucosidase inhibitor that delays carbohydrate digestion and glucose absorption in the small intestine, reducing postprandial hyperglycemia. DPP-4 is inhibited by sitagliptin. SGLT2 is inhibited by empagliflozin. Aldose reductase is not a target of standard oral hypoglycemics.

Reference: Katzung's Basic and Clinical Pharmacology, 15th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs

See all Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs →